149 related articles for article (PubMed ID: 18469150)
1. The role of eNOS, iNOS, and NF-kappaB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin.
Ye Y; Martinez JD; Perez-Polo RJ; Lin Y; Uretsky BF; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H343-51. PubMed ID: 18469150
[TBL] [Abstract][Full Text] [Related]
2. Pioglitazone protects the myocardium against ischemia-reperfusion injury in eNOS and iNOS knockout mice.
Ye Y; Lin Y; Manickavasagam S; Perez-Polo JR; Tieu BC; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2436-46. PubMed ID: 18931027
[TBL] [Abstract][Full Text] [Related]
3. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin.
Rosanio S; Ye Y; Atar S; Rahman AM; Freeberg SY; Huang MH; Uretsky BF; Birnbaum Y
Cardiovasc Drugs Ther; 2006 Feb; 20(1):27-36. PubMed ID: 16435070
[TBL] [Abstract][Full Text] [Related]
4. Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin.
Birnbaum Y; Lin Y; Ye Y; Martinez JD; Huang MH; Lui CY; Perez-Polo JR; Uretsky BF
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2891-7. PubMed ID: 17277020
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2.
Atar S; Ye Y; Lin Y; Freeberg SY; Nishi SP; Rosanio S; Huang MH; Uretsky BF; Perez-Polo JR; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1960-8. PubMed ID: 16339820
[TBL] [Abstract][Full Text] [Related]
6. Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions.
Ye Y; Lin Y; Atar S; Huang MH; Perez-Polo JR; Uretsky BF; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1158-69. PubMed ID: 16603698
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury.
Birnbaum Y; Ye Y; Rosanio S; Tavackoli S; Hu ZY; Schwarz ER; Uretsky BF
Cardiovasc Res; 2005 Feb; 65(2):345-55. PubMed ID: 15639473
[TBL] [Abstract][Full Text] [Related]
8. Statin treatment upregulates vascular neuronal nitric oxide synthase through Akt/NF-kappaB pathway.
Nakata S; Tsutsui M; Shimokawa H; Yamashita T; Tanimoto A; Tasaki H; Ozumi K; Sabanai K; Morishita T; Suda O; Hirano H; Sasaguri Y; Nakashima Y; Yanagihara N
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):92-8. PubMed ID: 17082483
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-kappaB dependent pathway.
Li Q; Guo Y; Tan W; Ou Q; Wu WJ; Sturza D; Dawn B; Hunt G; Cui C; Bolli R
Circulation; 2007 Oct; 116(14):1577-84. PubMed ID: 17785622
[TBL] [Abstract][Full Text] [Related]
10. The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation.
Merla R; Ye Y; Lin Y; Manickavasagam S; Huang MH; Perez-Polo RJ; Uretsky BF; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1918-28. PubMed ID: 17616749
[TBL] [Abstract][Full Text] [Related]
11. The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation.
Manickavasagam S; Ye Y; Lin Y; Perez-Polo RJ; Huang MH; Lui CY; Hughes MG; McAdoo DJ; Uretsky BF; Birnbaum Y
Cardiovasc Drugs Ther; 2007 Oct; 21(5):321-30. PubMed ID: 17620005
[TBL] [Abstract][Full Text] [Related]
12. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells.
Kolyada AY; Fedtsov A; Madias NE
Hypertension; 2001 Nov; 38(5):1024-9. PubMed ID: 11711492
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ.
Wagner AH; Schwabe O; Hecker M
Br J Pharmacol; 2002 May; 136(1):143-9. PubMed ID: 11976279
[TBL] [Abstract][Full Text] [Related]
15. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase.
Landmesser U; Engberding N; Bahlmann FH; Schaefer A; Wiencke A; Heineke A; Spiekermann S; Hilfiker-Kleiner D; Templin C; Kotlarz D; Mueller M; Fuchs M; Hornig B; Haller H; Drexler H
Circulation; 2004 Oct; 110(14):1933-9. PubMed ID: 15466656
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice.
Laufs U; Gertz K; Huang P; Nickenig G; Böhm M; Dirnagl U; Endres M
Stroke; 2000 Oct; 31(10):2442-9. PubMed ID: 11022078
[TBL] [Abstract][Full Text] [Related]
17. Caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat.
Ye Y; Abu Said GH; Lin Y; Manickavasagam S; Hughes MG; McAdoo DJ; Perez-Polo RJ; Birnbaum Y
Cardiovasc Drugs Ther; 2008 Aug; 22(4):275-82. PubMed ID: 18327703
[TBL] [Abstract][Full Text] [Related]
18. p38 Triggers late preconditioning elicited by anisomycin in heart: involvement of NF-kappaB and iNOS.
Zhao TC; Taher MM; Valerie KC; Kukreja RC
Circ Res; 2001 Nov; 89(10):915-22. PubMed ID: 11701619
[TBL] [Abstract][Full Text] [Related]
19. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.
Das A; Salloum FN; Xi L; Rao YJ; Kukreja RC
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1236-43. PubMed ID: 19286961
[TBL] [Abstract][Full Text] [Related]
20. Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart.
Birnbaum Y; Ye Y; Lin Y; Freeberg SY; Huang MH; Perez-Polo JR; Uretsky BF
Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):89-98. PubMed ID: 17259075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]